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From the more than 100 liver diseases described, many of those
with high incidence rates manifest themselves by histopatholo-
gical changes, such as hepatitis, alcoholic liver disease, fatty liver
disease, ﬁbrosis, and, in its later stages, cirrhosis, hepatocellular
carcinoma, primary biliary cirrhosis and other disorders. Studies
of disease pathogeneses are largely based on integrating -omics
data pooled from cells at different locations with spatial informa-
tion from stained liver structures in animal models. Even though
this has led to signiﬁcant insights, the complexity of interactions
as well as the involvement of processes at many different time
and length scales constrains the possibility to condense disease
processes in illustrations, schemes and tables. The combination
of modern imaging modalities with image processing and analy-
sis, and mathematical models opens up a promising new
approach towards a quantitative understanding of pathologies
and of disease processes. This strategy is discussed for two exam-
ples, ammonia metabolism after drug-induced acute liver dam-
age, and the recovery of liver mass as well as architecture
during the subsequent regeneration process. This interdisciplin-
ary approach permits integration of biological mechanisms and
models of processes contributing to disease progression at vari-
ous scales into mathematical models. These can be used to per-
form in silico simulations to promote unravelling the relation
between architecture and function as below illustrated for liver
regeneration, and bridging from the in vitro situation and animal
models to humans. In the near future novel mechanisms will
usually not be directly elucidated by modelling. However, modelsJournal of Hepatology 20
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Introduction (Fig. 1)
While recent developments have signiﬁcantly increased our
capability to collect information at multiple spatial and temporal
scales, research in disease pathogenesis is largely hampered by
the difﬁculty to orchestrate the individual components and
mechanisms inferred by traditional ways of analysis into a con-
sistent picture and to infer a complex interplay of components
by pure reasoning. Here, mathematical models can play an
important role as they formalise relations between components,
quantify components and mechanisms, and test their interplay
in a virtual setting deﬁned by the modeller, thus, avoiding possi-
ble perturbations by unknown inﬂuences that can rarely be
excluded in a real biological system. Mathematical models
addressing liver pathology or drug effects increasingly integrate
different levels of organisation [1]. Extra-hepatic contributions
are usually addressed by compartment models [2,3], material
transport (blood, lymph, bile) in liver or individual lobules by
perfusion models considering local averages of concentrations,
volume fractions and ﬂow speed [4–7], Poiseuille-like ﬂow [8]
or spatial compartment models [9,10]. Hepatocytes, stellate cells,
sinusoidal endothelial cells or other cell types may be included as
cell compartments or as individual entities in space [8,11–13].
Metabolism, signal transduction or gene expression is usually
modelled by systems of ordinary differential equations
[9,14,15]. Model parameters, components or mechanisms can
readily be modiﬁed, suppressed or added and the impact of such
changes can be studied on different system observables. How-
ever, mathematical models remain abstractions of their biological
counterpart. The aim is not an ‘in silico duplicate’ of the ‘real bio-
logical system’ as this would have the same complexity as the
original system. The choice of model components, horizontally
on the same scale as vertically spanning several scales, should
be guided by a scientiﬁc question.
Ideally all model parameters would be measured simulta-
neously but we are currently far from such an ideal situation.
Therefore, the model parameters shall represent measurable
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Fig. 1. Workﬂow from scientiﬁc question to possible answer. (A) Once the scientiﬁc question has been deﬁned, hypothetical alternative mechanisms which could
underlie the disease pathogenesis should be formulated. (B) In a next step, data has to be collected to inform the model quantitatively about initial conditions (the starting
state), boundary conditions (values at the border of spatial domains, in/outﬂows etc.), and the condition(s) at which the model simulation should stop. Histopathology is
characterised by the tissue composition (e.g., the cell types and extracellular matrix) and their architecture. It can be quantitatively described by a set {P1} of composition
and architectural parameters (C) [12]. Such parameters can be inferred from a data analysis pipeline of imaging, image processing and analysis (C, [18]), serving as a starting
state for the model simulations (E1). Both, data of a concrete individual tissue specimen or representative data obtained from the statistical distribution functions over the
(architectural) parameters of many individuals can be used. Quantitative information about the disease process can be obtained from series of images in an equivalent way
and leads to a second set of parameters {P2} (C). This parameter set must be explained by the model (D). The mathematical model should represent the hypothetical
alternative mechanisms, and permit testing them in silico one by one. It introduces a third parameter set {P3}. If even after calibration of each model parameter within its
range the model simulations (E1, E2) do not quantitatively capture the biologically observed behaviour, either important structures, mechanisms or processes that are
required to correctly capture the speciﬁc in vivo situation are likely to be missing. In such situations the model needs to be adjusted (F) until ﬁnally agreement between
model simulation results and experimental observations is achieved. It may occur that different mathematical models, each basing on another hypothetical mechanism,
explain the same data quantitatively. In this case it is possible to use the mathematical model to search for an experimental situation in which the different hypothesis
would predict different outcomes (G). Such an ‘informative’ experiment permits to select the correct out of several principally possible explanations.
Clinical Application of Basic Sciencequantities with a (known) direct physical or biological meaning
and interpretation as this largely facilitates estimation of their
range. Parameterization base on heuristics (experience-based
techniques) should be avoided, as those parameter values are dif-
ﬁcult to estimate. Each parameter that is not experimentally
quantiﬁed introduces a degree of freedom that has to be explored
by simulation, thereby increasing the search space of the model.
For this reason, it is useful to construct a minimal model param-
eterised by the measurable quantities compatible with published
knowledge.
As many liver diseases leave a signature in the composition
and architecture of liver tissue in which case pathophysiology
and histopathology are inherently linked the focus here is on
quantitative (as opposed to qualitative) models involving liver
mass and architecture. Fig. 1 sketches how a process chain con-
sisting of experiment, data analysis and mathematical modelling
can be iteratively applied to promote our understanding of liver
disease pathogenesis.
In the next two sections we illustrate the workﬂow along
two examples, the regeneration of liver mass and architecture
after CCl4-induced damage addressing the cell and tissue scale
[12], and ammonia detoxiﬁcation after CCl4-induced damage
addressing ammonia metabolism [10]. As our examples show,952 Journal of Hepatology 201mechanisms can often only be ruled out if the model is
quantitative.A model on cell and tissue scale: Identiﬁcation of key
mechanisms of regeneration after drug-induced acute
damage (Fig. 2)
Toxic doses of acetaminophen (APAP) can induce necrosis in the
centre of the liver lobules [16] (Fig. 2A). A similar pericentral
lesion is caused by the hepatotoxic model compound CCl4. The
extent of damage can amount to 30–40% of the total liver volume.
In only approximately ten days livers of rodents not only regen-
erate their original cell numbers but also restore their functional
tissue microarchitecture. This includes the process of reorganis-
ing the complex sinusoidal structure with endothelial cells and
sheets of hepatocytes. The necessity of coordinating principles
is obvious, since the starting situation of the regeneration process
is a seemingly ‘chaotic’ dead cell mass. Much research has been
done to understand the mechanisms controlling hepatocyte and
non-parenchymal cell proliferation during regeneration [16,17].
However, only little is known how cells act coordinated to restore
functional tissue microarchitecture. This question is of practical4 vol. 61 j 951–956
Fig. 2. Application of the work ﬂow described in Fig. 1 to the example of liver regeneration after CCl4-induced damage (from [12]). Based on the question (gray, A)
how the regeneration of liver mass and architecture could be explained, experiments (orange, B) were performed to parameterise the tissue architecture obtaining
parameters {P1} (green, C, volume visualisation) and the regeneration process obtaining parameters {P2} (green, C, plots). Confocal laser scanning micrographs of relatively
thick (100 lM) tissue blocks were used to reconstruct the lobule architecture as physical cutting necessary for bright ﬁeld micrographs rendered registration of sinusoids
impossible. To establish the model each individual hepatocyte was represented. To inform the model about the regeneration process, the following process parameters {P2}
were experimentally determined and included into the model: (i) the number of hepatocytes per mm2 within a lobule to represent liver mass, (ii) the size of the necrotic
lesion, (iii) the fraction of interface between hepatocytes and sinusoids as a measure of the ‘functional architecture’ as it informs about the exchange area for metabolites
between blood and hepatocytes, and (iv) the fraction and spatial-temporal distribution of BrdU-stained nuclei as a measure of S-phase entry. Parameter (iv) served as a
model input parameter, (i–iii) to evaluate the model. Experimental quantiﬁcation of the process parameters showed that the number of hepatocytes per lobule had a
minimum at day two, the necrotic lesion area a maximum at day one, and the fraction of the hepatocyte surface not in contact with another hepatocyte a minimum at day
four after CCl4 damage. The recovery of architecture followed that of mass with a delay of approximately one week. The ﬁnal model was developed in three iterations. The
ﬁrst model M1 assumed: (a) a hepatocyte in isolation can be approximated as a homogeneous, isotropic elastic sphere, cohere to another hepatocyte and (in principle)
adhere to sinusoids. (b) Micromotility is undirected and random. (c) A moving hepatocyte experiences friction with the extra-cellular matrix in the space of Disse and with
sinusoids. (d) In the cell cycle, a hepatocyte doubles its volume and then splits into two hepatocyte daughter cells of equal volume. (e) Sinusoids were mimicked by a chain
of spheres linked by elastic springs, and anchored in the central vein and the portal ﬁeld. Hepatocyte movement was calculated solving an equation of motion for each
hepatocyte summing contributions from the cells’ micromotiliy and all physical forces exerted on the cell by its environment. For each sphere belonging to a sinusoid a
similar equation of motion was solved omitting micromotiliy. As the model was completely parameterized by measurable parameters {P3}, the range of each model
parameter could be estimated. Both, tissue architecture {P1} and process {P2} parameters were used to construct an agent-based model (violet, D) for the regenerating liver
lobule. The ﬁrst iteration showed that proliferation pressure (illustrated as a compressed spring in (F1)) is not sufﬁcient to close the lesion and restore architecture (red
curves in (E)). Based on this disagreement, the model was adjusted in two steps (light blue, F1–F3). Firstly, in M2 the random undirected micromotility was replaced by
directed migration into the necrotic zone leading to a relaxation of the proliferation pressure (illustrated in (F2) by a stretched spring). As a consequence the lesion could be
closed in time but the architecture could still not be restored (blue lines in (E)). Only when the random orientation of cell division (indicated by the two red cells not aligned
along the chain of many small red circles representing the sinusoid in the scheme of F2) was replaced by (M3) cell division oriented along the closest sinusoid (represented
by two red cells lining along the sinusoid in (F3)) all process parameters could be correctly explained (green curves). The model further correctly predicted the
experimentally determined angle distribution of the daughter cells emerging from the same precursor hepatocyte (red, G).
JOURNAL OF HEPATOLOGYrelevance, since the responsible ‘coordinating mechanism’ seems
to be efﬁcient under conditions of acute liver damage where a full
regeneration is possible. However, it seems to fail under condi-Journal of Hepatology 201tions of chronic exposure or inﬂammation which often lead to
irreversibly disturbed tissue architecture and function. The ques-
tion of the ‘coordinating principle’ that controls restoration of4 vol. 61 j 951–956 953
Fig. 3. Application of the work ﬂow described in Fig. 1 to an integrated model of ammonia detoxiﬁcation after CCl4-induced pericentral necrosis (gray, A). In
experiment 1 (orange, B) the size of the glutamine synthetase (GS) labeled zone around the central vein and the size of the necrotic lesion after CCl4-induced damage were
determined time-dependently. This information served to construct a spatial-temporal tissue model (STM) (violet, D-Right, see also Fig. 2) capable of simulating the
pericentral, GS-positive and the periportal GS-negative volumes. Experiment 2 represents ex vivo antegrade and retrograde perfusion experiments with different
concentrations of ammonia to determine the concentrations of ammonia, glutamine and urea in the outﬂow (orange B). This information has been used to calibrate a kinetic
metabolic model (MM) representing the key reactions of ammonia detoxiﬁcation [24] (violet, D, left). These are the glutaminase reaction converting glutamine into
ammonia and glutamate, and carbamoyl phosphate synthetase fundamentally converting ammonia into urea, both in the periportal compartment, and the glutamine-
synthetase catalysed reaction of ammonia and glutamate into glutamine, in the pericentral compartment. Brieﬂy, the key reactions of ammonia detoxiﬁcation (Fig. 3,
[22,23]) were translated into a metabolic model (MM) for healthy liver comprising of an ordinary differential equation for each glutamine, urea and ammonia in the
periportal and the pericentral compartment. In a ﬁnal step the volumes in the MM after CCl4 administration were calculated from the STM arriving at an integrated
metabolic model (IMM) (violet, D). Simulations with this model were compared with a new set of experiments (blue, E) on the concentrations of ammonia, glutamine and
urea in the right heart chamber, portal vein and hepatic vein of mice. Quantitative agreement could only be achieved after adding a hypothetical ammonia consuming
reaction (light blue, F) which next requires validation (red G). (from [10], details see Supplementary data).
Clinical Application of Basic Sciencetissue architecture was addressed by a spatio-temporal model-
ling approach [12] (Fig. 2). Possible hypothetical mechanisms
(H) that could either alone or in combination explain the efﬁcient
restoration of liver architecture were: (H1) hepatocytes could
move individually into the necrotic lesion, and close it by cell
division, (H2) the border between healthy hepatocytes and cen-
tral necrosis could be pushed by proliferation pressure towards
the necrotic lesion following a mechanical gradient, (H3) hepato-
cytes could migrate actively collectively, directed towards the
necrotic lesion, (H4) cell division could be randomly undirected,
or (H5) directed along a portal-central molecular gradient, or
(H6) directed along the closest sinusoid. To determine the start-
ing state a spatial-temporal model (STM) of the 3D liver lobule
architecture was reconstructed from confocal laser scanning
micrographs (Fig. 2B) by a speciﬁcally designed image processing954 Journal of Hepatology 201and analysis chain ([12,18], Fig. 2C, Supplementary data). By this
technique the static architectural liver lobule parameters {P1}
such as the size and shape of hepatocytes, diameter, density
and branching parameters of sinusoids, the size and variability
of liver lobules, etc., were deﬁned. Next, the process parameters
{P2} describing the damage and regeneration process were deter-
mined. This includes the time-resolved quantiﬁcation of the
numbers of hepatocytes, size of lesion, BrdU incorporation and
architectural parameters (Fig. 2, caption, Fig. 2C).
As initial model conﬁguration either a concrete 3D recon-
structed lobule was chosen, or a representative liver lobule
(Fig. 2D) was established by sampling from the static liver lobule
parameter distributions (Supplementary data). The assumptions
of this model, named model 1 (M1), are summarised in Fig. 2
(caption) and detailed in the Supplementary data. Hundreds of4 vol. 61 j 951–956
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simulations varying each model parameter within its pre-deter-
mined physiological range were performed. The best simulations
with M1 including the experimentally determined proliferation
rate could explain the number of hepatocytes in the lobule but
failed to explain the closure of the necrotic lesion and the lobule
architecture (red curves in Fig. 2E). Therefore, the proliferation
pressure alone was insufﬁcient to close the lesion (Fig. 2F1) elim-
inating mechanism H2 and requiring model adjustment. Moti-
vated by the observation that hepatocytes at the border to the
necrotic lesion stretched lamellipodia into the lesion, in M2 the
random micromotility was replaced by a directed active migra-
tion of hepatocytes at the border of the lesion into the necrotic
zone (Fig. 2F2, details in Supplementary data). As isolated cells
were not found in the lesion (eliminating H1), only parameters
{P3} for which the migration was collective where considered
(H3). The 2nd model could explain the closure of the lesion but
failed to explain the regeneration of liver architecture, hence
H3 was also insufﬁcient. For further adjustment it was hypothe-
sised that daughter hepatocytes after cell division undergo a pro-
cess of ‘hepatocyte-sinusoid alignment’ (HSA) meaning that an
axis through the centre of the daughter cells is oriented in paral-
lel to the direction of the closest sinusoid (HSA, H5, M3, Fig. 2F3,
details in Supplementary data), eliminating H4. One of the obser-
vations motivating this hypothesis was that almost all hepato-
cytes were killed in the peri-central region after CCl4 but a
remarkable fraction of the sinusoidal endothelial cells survived.
Only after inclusion of HSA into the model all process param-
eters could be correctly explained. This model prediction was
experimentally validated by confocal laser scanning micrographs
co-stained with BrdU to label daughter cells and ICAM/DPPIV to
identify the sinusoids. The same experiments did not support
an orientation of cell division along a portal-central morphogen
gradient because the sinusoids did not precisely orient in radial
direction, ruling out H6. Therefore, the modelling studies have
clearly shown that liver sinusoidal endothelial cells (LSEC) spa-
tio-temporally orchestrate liver regeneration [11,12]. The precise
molecular mechanisms of this process have later been elucidated
by other groups [19–21]. LSEC deploy paracrine trophogens to
allow liver regeneration [19]. Of particular relevance seems to
be the release of the angiocrine factors Wnt2 and HGF from LSEC
that have been reported to induce hepatocyte proliferation [21].
Moreover, the expression of Angiopoietin-2 (Ang2) in LSECs is
dynamically regulated during liver regeneration. Ang2 down-reg-
ulation leads to reduced TGF-b1 release from LSEC, enabling
hepatocyte proliferation [20]. In conclusion, LSECs represent
key regulators of liver regeneration that not only control prolifer-
ation but also serve as ‘guide rails’ for hepatocytes controlling
their orientation and architecture in the liver lobule.An integrated model of ammonia detoxiﬁcation after CCl4-
induced damage (Fig. 3)
The metabolic pathways of ammonia detoxiﬁcation in the liver
have been intensively studied [22,23]. In the periportal compart-
ment of the liver lobule ammonia is detoxiﬁed by urea cycle
enzymes. Moreover, a ring of pericentral hepatocytes metabolises
ammonia by glutamine synthetase. It is well established that
ammonia blood concentrations can increase upon induction of
liver damage. However, only little is known about ammonia
metabolism in damaged livers. Does the extent of decreasedJournal of Hepatology 201metabolism correspond to the fraction of destroyed tissue
(H1)? Or are additional metabolic pathways active that do not
occur in the healthy liver (H2)? To come closer to an answer a
metabolic model (MM) was established by expressing the
reactions involved in ammonia detoxiﬁcation by a set of differen-
tial equations to calculate the concentrations of ammonia and its
metabolites in the liver vein (‘outﬂow’) for a given concentration
in the portal vein and artery (‘inﬂow’) (Fig. 3D summarises the
model assumptions, details see Supplementary data; [10]). From
mass balance the volumes of the periportal and pericentral lobule
compartments enter the MM as reaction volumes. Consequently,
destruction of liver tissue leads to a reduction of the volume of
the compartments and consequently to reduced capability of per-
iportal and/or pericentral ammonia detoxiﬁcation. Since the spa-
tio-temporal model described in the previous paragraph [12]
simulates the time course of lobule destruction after acute CCl4
toxicity (Fig. 3B1), it was used as a basis and linked to the meta-
bolic model (Fig. 3D and E). The parameters of this model were
calibrated with results from experiments, where mouse liver
was perfused ante-and retrograde with buffers containing differ-
ent ammonia concentrations (Fig. 3B2). A quantitative agreement
between simulation results and experimental data could be
achieved. In a next step, the so calibrated MMwas used to predict
the temporal ammonia and glutamine concentrations in the
hepatic vein of mice after CCl4-induced damage where the exper-
imentally determined concentrations in the portal vein and right
heart chamber (representing the portal artery) were used as
inﬂow.
While in healthy liver the pericentral and -portal volumes
remain stationary, after CCl4-induced damage they change over
time. These volumes were calculated from the spatial temporal
model (STM) introduced in Fig. 2, and inserted into the MM arriv-
ing at an integrated metabolic model (IMM). The IMM consists of
two parts, a kinetic equation model with time-dependent vol-
umes yielding the outﬂow glutamine, ammonia and urea concen-
trations in the hepatic vein (Fig. 3D, left (only ammonia shown)),
and a spatial temporal visualization of the concentration in the
liver lobule (Fig. 3D, right). It could be shown that despite quali-
tative agreement no quantitative agreement between IMM and
experiments after CCl4-induced damage could be achieved, lead-
ing to the conclusion that the reaction scheme is incomplete. The
IMM further predicted quantitative agreement if an additional
ammonia sink was introduced. Very recent ﬁndings triggered
by the model prediction identiﬁed a candidate for such a reaction
that is currently validated [25] and that may prospectively be
used to reduce ammonia concentrations in hyperammonemia.
The example illustrates that modelling can indicate a missing ele-
ment in ‘state-of-the art’ concepts and assist establishment of the
correct mechanisms.Conclusion
In the near future, we should not expect that models will directly
identify novel mechanisms. However, models can be utilised to
falsify hypotheses and to guide towards the most informative
experiment. It has proven useful and efﬁcient in physics that val-
idation experiments are not necessarily performed by the same
consortium that generated the model prediction. Validation
experiments may require a different expertise than needed to
generate the model. A limitation may be the time required for4 vol. 61 j 951–956 955
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the iterative cycles of modelling and experimental validation. To
speed up these iterations, it is important that workﬂow, imaging,
image processing and analysis [18] as well as modelling tools are
being developed in a standardised way well geared to each other.
In future, the mathematical models will become increasingly
mechanistic, integrating biological, chemical and physical pro-
cesses at multiple spatial and temporal scales. They will also
become more user-friendly so that at least some basic versions
can be directly applied by experimentalists.
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